Cell Impact (OSTO:CI) Earnings per Share (Diluted): kr-0.34 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cell Impact Earnings per Share (Diluted)?

Cell Impact OSTO:CI -6.85% Earnings per Share (Diluted) is kr-0.34 as of Jun. 2026. The stock has 7 warning signs investors should review. Among 2,425 Industrial Products companies, Cell Impact ranks better than 82.06% on this metric.

Cell Impact's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was kr-0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was kr-0.34.

Cell Impact's EPS (Basic) for the three months ended in Jun. 2026 was kr-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was kr-0.34.

Cell Impact's EPS without NRI for the three months ended in Jun. 2026 was kr-0.03. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was kr-0.34.

During the past 3 years, the average EPS without NRIGrowth Rate was 32.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -3.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was -11.10% per year.

During the past 13 years, Cell Impact's highest 3-Year average EPS without NRI Growth Rate was 33.80% per year. The lowest was -166.00% per year. And the median was -1.80% per year.


Cell Impact  (OSTO:CI) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cell Impact Earnings per Share (Diluted) Related Terms


Cell Impact Earnings per Share (Diluted) Historical Data

* Premium members only.

The historical data trend for Cell Impact's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact Earnings per Share (Diluted) Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.78 -1.82 -4.62 -6.75 -0.56

Cell Impact Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.10 -0.17 -0.04 -0.03

OSTO:CI vs ATI, CRS, MLI: Earnings per Share (Diluted) Comparison

For the Metal Fabrication subindustry, Cell Impact's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Impact PE Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Cell Impact's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cell Impact's PE Ratio falls into.



Cell Impact Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Cell Impact's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as

Diluted Earnings Per Share (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-131.984-0)/234.620
=-0.56

Cell Impact's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2026 is calculated as

Diluted Earnings Per Share (Q: Jun. 2026 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-17.649-0)/566.938
=-0.03

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

What does a Earnings per Share (Diluted) of kr-0.34 mean?
Cell Impact (OSTO:CI) has a Earnings per Share (Diluted) of kr-0.34 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #435 out of 2425 companies in the Industrial Products industry, placing it in the top 17.9%.
Is Cell Impact's Earnings per Share (Diluted) too high?
Cell Impact's current Earnings per Share (Diluted) is kr-0.34. Based on the distribution chart, Cell Impact ranks #435 out of 2425 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers.
How does Cell Impact's Earnings per Share (Diluted) compare to ATI and CRS?
According to the Industrial Products industry distribution chart, Cell Impact ranks #435 out of 2425 companies for Earnings per Share (Diluted). This places Cell Impact in the top 18% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 3.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for an Industrial Products company?
The median Earnings per Share (Diluted) among Industrial Products companies is 3.70, based on 2,425 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median Earnings per Share (Diluted) is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current Earnings per Share (Diluted) is kr-0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.03, compared to a current price of kr0.05 — trading 58.7% above its estimated fair value. The current Earnings per Share (Diluted) is kr-0.34. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current Earnings per Share (Diluted) is kr-0.34 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges ICL:Germany
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.